Current Medical Research and Opinion logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 24, Number 9, September 2008

< previous issue | all issues | next issue >

Original Articles

Five-year routine cervical cancer screening rates and intervals in a US health plan
pp. 2429-2435(7)
Authors: Schabert, Vernon F.; Ye, Xin; Insinga, Ralph P.; Singhal, Puneet K.; Riedel, Aylin A.

Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes
pp. 2437-2447(11)
Authors: Forti, Adriana; Garcia, Eduardo Garcia; Yu, Maria B.; Jimenez, Maria C.; Brodows, Robert G.; Oliveira, Juliana H.

Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers
pp. 2449-2456(8)
Authors: Huang, H.L.A.; Vaidyanathan, S.; Yeh, C.M.; Bizot, M.N.; Dieterich, H.A.; Dole, W.P.; Howard, D.

The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder
pp. 2457-2466(10)
Authors: Sheehan, David V.; Meyers, Adam L.; Prakash, Apurva; Robinson, Michael J.; Swindle, Ralph W.; Russell, James M.; Mallinckrodt, Craig H.

Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins
pp. 2477-2487(11)
Authors: Bergheanu, Sandrin C.; Reijmers, Theo; Zwinderman, Aeilko H.; Bobeldijk, Ivana; Ramaker, Raymond; Liem, An-Ho; van der Greef, Jan; Hankemeier, Thomas; Jukema, J. Wouter

Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany
pp. 2489-2499(11)
Authors: Berger, Ariel; Sadosky, Alesia; Dukes, Ellen; Martin, Susan; Edelsberg, John; Oster, Gerry

The burden of illness of hypertension and comorbid diabetes
pp. 2501-2507(7)
Authors: Eaddy, Michael T.; Shah, Manan; Lunacsek, Orsolya; Stanford, Richard H.

Review

Brief Report

Effect of non-persistent use of oral glucose-lowering drugs on HbA1c goal attainment
pp. 2523-2529(7)
Authors: Penning-van Beest, Fernie J.A.; van der Bij, Sjoukje; Erkens, Joëlle A.; Kessabi, Sophia; Groot, Martijn; Herings, Ron M.C.

Original Articles

Prefilled insulin device with reduced injection force: patient perception and accuracy
pp. 2545-2549(5)
Authors: Pfützner, A.; Reimer, T.; Hohberg, C.; Frøkjær, L.P.F.; Jørgensen, C.

Abnormal lipids in high-risk patients achieving cholesterol targets: a cross-sectional study of routinely collected UK general practice data
pp. 2551-2560(10)
Authors: Belsey, Jonathan; de Lusignan, Simon; Chan, Tom; van Vlymen, Jeremy; Hague, Nigel

Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study
pp. 2561-2574(14)
Authors: Ballard, C.; Sauter, M.; Scheltens, P.; He, Y.; Barkhof, F.; van Straaten, E.C.W.; van der Flier, W.M.; Hsu, C.; Wu, S.; Lane, R.

Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia
pp. 2575-2585(11)
Authors: Tzeng, Tsang-Bin; Schneck, Dennis W.; Birmingham, Bruce K.; Mitchell, Patrick D.; Zhang, Harry; Martin, Paul D.; Kung, Li-Pin

Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population
pp. 2587-2595(9)
Authors: Wu, Eric; Greenberg, Paul E.; Yang, Elaine; Yu, Andrew; Erder, M. Haim

Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations
pp. 2597-2607(11)
Authors: Brixner, Diana I.; Jackson, Kenneth C.; Sheng, Xiaoming; Nelson, Richard E.; Keskinaslan, Abdulkadir

Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis
pp. 2609-2615(7)
Authors: Marini, Francesca; Falchetti, Alberto; Silvestri, Sandra; Bagger, Yu; Luzi, Ettore; Tanini, Annalisa; Christiansen, Claus; Brandi, Maria Luisa

Review

Original Article

Commentary

Good glycaemic control: an international perspective on bridging the gap between theory and practice in type 2 diabetes
pp. 2651-2661(11)
Authors: Kilpatrick, E.S.; Das, A.K.; Ørskov, C.; Berntorp, K.

Brief Report

Reviews

Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis
pp. 2679-2690(12)
Authors: Moses, Harold; Brandes, David W.

Commentary

Original Articles

Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy
pp. 2703-2709(7)
Authors: Belsey, Jonathan; de Lusignan, Simon; van Vlymen, Jeremy; Chan, Tom; Hague, Nigel

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey
pp. 2711-2717(7)
Authors: Zhang, Bin; Menzin, Joe; Friedman, Mark; Korn, Jonathan R.; Burge, Russel T.

Brief Report

Observational study of sublingual specific immunotherapy in persistent and intermittent allergic rhinitis: the EFESO trial
pp. 2719-2724(6)
Authors: Milani, Massimo; Pecora, Silvia; Burastero, Samuele; EFESO Investigators Study Group,

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page